Combination of diclofenac and aggressive hydration for the prevention of post-ERCP pancreatitis

Mehri Hajalikhani, Mohammad Hassan Emami, Mahsa Khodadoostan, Ahmad Shavakhi, Moeen Rezaei, Reza Soluki

Abstract


35

Aim: To investigate whether aggressive hydration can increase the efficacy of prophylactic non-steroid anti-inflammatory drugs
(NSAIDs) in prevention of post-ERCP pancreatitis.
Background: NSAIDs are recommended for the prevention of PEP; however, whether aggressive hydration can have additional
benefits in this regard is not known.
Methods: Patients candidate for ERCP received either pre-procedural rectal diclofenac (100 mg) alone (n = 112) or in combination
with aggressive hydration by lactate ringer’s (n = 107) as prophylactic method. PEP was defined based on increase in serum levels of
pancreatic enzymes (from baseline to 24 hours following the procedure) accompanied with symptoms.
Results: PEP was occurred in 3 patients in the diclofenac only group and in 1 patient in the diclofenac + hydration group with no
significant difference (2.7% vs. 0.9%, P = 0.622). Serum amylase levels decreased over time in the diclofenac + hydration group but
not in the diclofenac only group. Also, serum lipase levels decreased more rapidly over time in the diclofenac + hydration group
compared to the diclofenac only group.
Conclusion: Combination prophylactic therapy with NSAIDs plus aggressive hydration does not seem to have additional clinically
important benefits in preventing PEP. Studies with larger sample of patients are required in this regard.
Keywords: Pancreatitis, Endoscopic retrograde cholangiopancreatography, Prevention, Inflammation, Diclofenac, Aggressive
hydration.
(Please cite as: Hajalikhani M, Emami MH, Khodadoostan M, Shavakhi A, Rezaei M, Soluki R. Combination of
diclofenac and aggressive hydration for the prevention of post-ERCP pancreatitis. Gastroenterol Hepatol Bed
Bench 2018;11(4):319-324).


Keywords


pancreatitis, endoscopic retrograde cholangiopancreatography, prevention, inflammation, diclofenac, aggressive hydration

Full Text:

PDF - View Count=0

References


- Andriulli A, Loperfido S, Napolitano G, Niro G, Valvano MR, Spirito F, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007;102(8):1781-8. PMID: 17509029.

- Kochar B, Akshintala VS, Afghani E, Elmunzer BJ, Kim KJ, Lennon AM, et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc. 2015 Jan;81(1):143-149. PMID: 25088919.

- Masci E, Mariani A, Curioni S, Testoni PA. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy. 2003;35(10):830-4. PMID: 14551860.

- Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54(4):425-34. PMID: 11577302.

- Choudhary A, Bechtold ML, Arif M, Szary NM, Puli SR, Othman MO, et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc. 2011;73(2):275-82. PMID: 21295641.

- Mazaki T, Mado K, Masuda H, Shiono M. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis. J Gastroenterol. 2014 Feb;49(2):343-55. PMID: 23612857.

- ASGE Standards of Practice Committee, Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D, et al. Adverse events associated with ERCP. Gastrointest Endosc. 2017;85(1):32-47. PMID: 27546389.

- Patai Á, Solymosi N, Mohácsi L, Patai ÁV. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials. Gastrointest Endosc. 2017;85(6):1144-1156. PMID: 28167118.

-Hou YC, Hu Q, Huang J, Fang JY, Xiong H. Efficacy and safety of rectal nonsteroidal anti-inflammatory drugs for prophylaxis against post-ERCP pancreatitis: a systematic review and meta-analysis. Sci Rep. 2017;7:46650. PMID: 28440297.

- Ishiwatari H, Urata T, Yasuda I, Matsusaki S, Hisai H, Kawakami H, et al. No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Dig Dis Sci. 2016;61(11):3292-3301. PMID: 27447477.

- Lee TY, Choi JS, Oh HC, Song TJ, Do JH, Cheon YK. Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study. Korean J Intern Med. 2015 Sep;30(5):602-9. PMID: 26354054.

- Dumonceau JM, Andriulli A, Elmunzer BJ, Mariani A, Meister T, Deviere J, et al. European Society of Gastrointestinal Endoscopy. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014. Endoscopy. 2014;46(9):799-815. PMID: 25148137.

- Wu D, Wan J, Xia L, Chen J, Zhu Y, Lu N. The Efficiency of Aggressive Hydration With Lactated Ringer Solution for the Prevention of Post-ERCP Pancreatitis: A Systematic Review and Meta-analysis. J Clin Gastroenterol. 2017 Sep;51(8):e68-e76. PMID: 28609383.

- Zhang ZF, Duan ZJ, Wang LX, Zhao G, Deng WG. Aggressive Hydration With Lactated Ringer Solution in Prevention of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis: A Meta-analysis of Randomized Controlled Trials. J Clin Gastroenterol. 2017;51(3):e17-e26. PMID: 28178088.

- Hosseini M, Shalchiantabrizi P, Yektaroudy K, Dadgarmoghaddam M, Salari M. Prophylactic Effect of Rectal Indomethacin Administration, with and without Intravenous Hydration, on Development of Endoscopic Retrograde Cholangiopancreatography Pancreatitis Episodes: A Randomized Clinical Trial. Arch Iran Med. 2016;19(8):538-43. PMID: 27544361.

- Mok SRS, Ho HC, Shah P, Patel M, Gaughan JP, Elfant AB. Lactated Ringer's solution in combination with rectal indomethacin for prevention of post-ERCP pancreatitis and readmission: a prospective randomized, double-blinded, placebo-controlled trial. Gastrointest Endosc. 2017;85(5):1005-1013. PMID: 27816497.

- Vege SS. Clinical manifestations and diagnosis of acute pancreatitis. Whitcomb DC, Grover Sh, ed. UpToDate. Waltham, MA: UpToDate Inc. http://www.uptodate.com (Accessed on Jun, 2018.)

- Levenick JM, Gordon SR, Fadden LL, Levy LC, Rockacy MJ, Hyder SMet al. Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients. Gastroenterology. 2016;150(4):911-7. PMID: 26775631.

- Luo H, Zhao L, Leung J, Zhang R, Liu Z, Wang X, et al. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial. Lancet. 2016 Jun 4;387(10035):2293-2301. PMID: 27133971.

- Mohammad Alizadeh AH, Abbasinazari M, Hatami B, Abdi S, Ahmadpour F, Dabir S. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis. Eur J Gastroenterol Hepatol. 2017;29(3):349-354. PMID: 27849643.

- Banks PA, Freeman ML; Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101(10):2379-400. PMID: 17032204.

- Park CH, Paik WH, Park ET, Shim CS, Lee TY, Kang C, et al. Aggressive intravenous hydration with lactated Ringer's solution for prevention of post-ERCP pancreatitis: a prospective randomized multicenter clinical trial. Endoscopy. 2018;50(4):378-385. PMID: 29237204.

- Buxbaum J, Yan A, Yeh K, Lane C, Nguyen N, Laine L. Aggressive hydration with lactated Ringer's solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol. 2014 Feb;12(2):303-7. PMID: 23920031.

- Buxbaum J, Yu CY. Indomethacin and lactated Ringer's hydration to prevent post-ERCP pancreatitis: right combination but wrong volume. Gastrointest Endosc. 2017;86(5):925-926. PMID: 29061261.




DOI: https://doi.org/10.22037/ghfbb.v11i4.1424

Creative Commons License
GHFBB by Gastroenterology and Liver Diseases Research Institute is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

PISSN: 2008-2258

EISSN: 2008-4234


•  

Privacy Policy | For Author | Online Submission | About | Contact

Copyright © 2018 Shahid Beheshti University of Medical Sciences. All rights reserved.